Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders

[1]  R. Krithiga.  DHS , 2019, Advances in Computerized Analysis in Clinical and Medical Imaging.

[2]  Gerome Breen,et al.  Genetic identification of brain cell types underlying schizophrenia , 2017, Nature Genetics.

[3]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[4]  Jakob Grove,et al.  Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection , 2018, Nature Genetics.

[5]  I. Scheffer,et al.  De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures. , 2017, American journal of human genetics.

[6]  J. Kennedy,et al.  De novo damaging coding mutations are strongly associated with obsessive-compulsive disorder and overlap with autism , 2017, bioRxiv.

[7]  T. Dinan,et al.  Cross Talk: The Microbiota and Neurodevelopmental Disorders , 2017, Front. Neurosci..

[8]  H. Stefánsson,et al.  Truncating mutations in RBM12 are associated with psychosis , 2017, Nature Genetics.

[9]  J. Krystal,et al.  Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders , 2017, Biological Psychiatry.

[10]  Jeffrey D. Mandell,et al.  De Novo Coding Variants Are Strongly Associated with Tourette Disorder , 2017, Neuron.

[11]  M. Daly,et al.  De novo variants in neurodevelopmental disorders with epilepsy , 2018, Nature Genetics.

[12]  B. Frey,et al.  Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder , 2017, Nature Neuroscience.

[13]  Michael F. Wangler,et al.  A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay. , 2017, American journal of human genetics.

[14]  Michael R. Johnson,et al.  Ultra-rare genetic variation in common epilepsies: a case-control sequencing study , 2017, The Lancet Neurology.

[15]  Roy Ben-Shalom,et al.  Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures , 2017, Biological Psychiatry.

[16]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[17]  Jiqiang Guo,et al.  Stan: A Probabilistic Programming Language. , 2017, Journal of statistical software.

[18]  Judith A. Blake,et al.  Mouse Genome Database (MGD)-2017: community knowledge resource for the laboratory mouse , 2016, Nucleic Acids Res..

[19]  Raphael A. Bernier,et al.  denovo-db: a compendium of human de novo variants , 2016, Nucleic Acids Res..

[20]  Stephan J Sanders,et al.  Refining the role of de novo protein truncating variants in neurodevelopmental disorders using population reference samples , 2016, Nature Genetics.

[21]  S. Brunak,et al.  A scored human protein–protein interaction network to catalyze genomic interpretation , 2017, Nature Methods.

[22]  Michael R. Johnson,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[23]  Michael R. Johnson,et al.  Rare and common epilepsies converge on a shared gene regulatory network providing opportunities for novel antiepileptic drug discovery , 2016, Genome Biology.

[24]  Christopher D. Brown,et al.  Increased burden of deleterious variants in essential genes in autism spectrum disorder , 2016, Proceedings of the National Academy of Sciences.

[25]  J. Lupski,et al.  De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease , 2016, Human Genetics.

[26]  Giulio Genovese,et al.  Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia , 2016, Nature Neuroscience.

[27]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[28]  Davis J. McCarthy,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[29]  Naomi R. Wray,et al.  Common schizophrenia alleles are enriched in mutation-intolerant genes and maintained by background selection , 2016, bioRxiv.

[30]  Tomas W. Fitzgerald,et al.  Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing , 2016, Nature Genetics.

[31]  Krishna R. Kalari,et al.  Beta-Poisson model for single-cell RNA-seq data analyses , 2016, Bioinform..

[32]  J. Marioni,et al.  Pooling across cells to normalize single-cell RNA sequencing data with many zero counts , 2016, Genome Biology.

[33]  Minna Männikkö,et al.  Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders , 2016, Nature Neuroscience.

[34]  Iuliana Ionita-Laza,et al.  De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia , 2016, Neuron.

[35]  E. Boerwinkle,et al.  dbNSFP v3.0: A One‐Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice‐Site SNVs , 2016, Human mutation.

[36]  Doug Speed,et al.  Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease , 2015, Nature Neuroscience.

[37]  A. Kanner.  Management of psychiatric and neurological comorbidities in epilepsy , 2016, Nature Reviews Neurology.

[38]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[39]  Zhong Sheng Sun,et al.  Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database , 2016, Molecular Psychiatry.

[40]  Steven E. Hyman,et al.  Genetic research in autism spectrum disorders , 2015, Current opinion in pediatrics.

[41]  G. Kirov,et al.  Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia , 2015, Neuron.

[42]  B. Ceulemans,et al.  Two male adults with pathogenic AUTS2 variants, including a two-base pair deletion, further delineate the AUTS2 syndrome , 2014, European Journal of Human Genetics.

[43]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[44]  Stephan J Sanders,et al.  The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment , 2015, Nature Communications.

[45]  J. Sebat,et al.  Spatiotemporal 16p11.2 Protein Network Implicates Cortical Late Mid-Fetal Brain Development and KCTD13-Cul3-RhoA Pathway in Psychiatric Diseases , 2015, Neuron.

[46]  K. Pollard,et al.  Genomic and network patterns of schizophrenia genetic variation in human evolutionary accelerated regions. , 2015, Molecular biology and evolution.

[47]  Tomas W. Fitzgerald,et al.  Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.

[48]  Juancarlos Chan,et al.  Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..

[49]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[50]  Elhanan Borenstein,et al.  The discovery of integrated gene networks for autism and related disorders , 2015, Genome research.

[51]  D. Rujescu,et al.  Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes , 2014, PloS one.

[52]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[53]  Epilepsy Phenome,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[54]  Edouard Henrion,et al.  De Novo Mutations in Moderate or Severe Intellectual Disability , 2014, PLoS genetics.

[55]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[56]  Michael R. Johnson,et al.  Describing the genetic architecture of epilepsy through heritability analysis , 2014, Brain : a journal of neurology.

[57]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[58]  Kathryn Roeder,et al.  Most genetic risk for autism resides with common variation , 2014, Nature Genetics.

[59]  Daniele Merico,et al.  Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder , 2014, Nature Genetics.

[60]  Seungtai Yoon,et al.  De novo Mutations in Schizophrenia Implicate Chromatin Remodeling and Support a Genetic Overlap with Autism and Intellectual Disability , 2014, Molecular Psychiatry.

[61]  Allan R. Jones,et al.  Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.

[62]  N. Šestan,et al.  The developmental transcriptome of the human brain: implications for neurodevelopmental disorders. , 2014, Current opinion in neurology.

[63]  Michael Q. Zhang,et al.  HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism. , 2014, Cell reports.

[64]  M. Bellgrove,et al.  Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system , 2014, Molecular Psychiatry.

[65]  E. Banks,et al.  De novo mutations in schizophrenia implicate synaptic networks , 2014, Nature.

[66]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[67]  M. Daly,et al.  Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.

[68]  D. Rujescu,et al.  Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets , 2013, Translational Psychiatry.

[69]  E. Ben-David,et al.  Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism , 2013, Molecular Psychiatry.

[70]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[71]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[72]  Kathryn Roeder,et al.  Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes , 2013, PLoS genetics.

[73]  L. Siever,et al.  Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.

[74]  De novo mutations in epileptic encephalopathies , 2013 .

[75]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[76]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[77]  Gavin Rumbaugh,et al.  Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses , 2012, Cell.

[78]  Jacy L. Wagnon,et al.  CELF4 Regulates Translation and Local Abundance of a Vast Set of mRNAs, Including Genes Associated with Regulation of Synaptic Function , 2012, PLoS genetics.

[79]  S. Levy,et al.  De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia , 2012, Nature Genetics.

[80]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[81]  D. Zheng,et al.  Allele-Biased Expression in Differentiating Human Neurons: Implications for Neuropsychiatric Disorders , 2012, PloS one.

[82]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[83]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[84]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[85]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[86]  Tao Wang,et al.  SynaptomeDB: an ontology-based knowledgebase for synaptic genes , 2012, Bioinform..

[87]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[88]  S Purcell,et al.  De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia , 2011, Molecular Psychiatry.

[89]  Albert J. Vilella,et al.  A high-resolution map of human evolutionary constraint using 29 mammals , 2011, Nature.

[90]  S. Lok,et al.  Increased exonic de novo mutation rate in individuals with schizophrenia , 2011, Nature Genetics.

[91]  Gregory M. Cooper,et al.  A Copy Number Variation Morbidity Map of Developmental Delay , 2011, Nature Genetics.

[92]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[93]  S. Grant,et al.  Characterization of the proteome, diseases and evolution of the human postsynaptic density , 2011, Nature Neuroscience.

[94]  C. Spearman.  The proof and measurement of association between two things. , 2015, International journal of epidemiology.

[95]  J. Stockman,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2010 .

[96]  R. Fisher.  On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .

[97]  M. Stephens,et al.  Bayesian statistical methods for genetic association studies , 2009, Nature Reviews Genetics.

[98]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[99]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[100]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[101]  M. Verhage,et al.  Munc18-1 in secretion: lonely Munc joins SNARE team and takes control , 2007, Trends in Neurosciences.

[102]  Arjen Brussaard,et al.  Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size , 2006, Proceedings of the National Academy of Sciences.

[103]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[104]  K. Lindblad-Toh,et al.  Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.

[105]  M. Newman,et al.  Finding community structure in very large networks. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[106]  Deepayan Sarkar,et al.  Detecting differential gene expression with a semiparametric hierarchical mixture method. , 2004, Biostatistics.

[107]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[108]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[109]  T. Südhof,et al.  Synaptic assembly of the brain in the absence of neurotransmitter secretion. , 2000, Science.

[110]  Adrian E. Raftery,et al.  MCLUST: Software for Model-Based Cluster Analysis , 1999 .

[111]  B S Brown,et al.  KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. , 1998, Science.

[112]  R. Morris,et al.  Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein , 1998, Nature.

[113]  Richard F. Thompson,et al.  Importance of the Intracellular Domain of NR2 Subunits for NMDA Receptor Function In Vivo , 1998, Cell.

[114]  E. Kandel,et al.  Genetic and Pharmacological Evidence for a Novel, Intermediate Phase of Long-Term Potentiation Suppressed by Calcineurin , 1998, Cell.

[115]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[116]  Alcino J. Silva,et al.  Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. , 1992, Science.

[117]  L. M. M.-T..  Theory of Probability , 1929, Nature.

[118]  R. Fisher.  019: On the Interpretation of x2 from Contingency Tables, and the Calculation of P. , 1922 .

[119]  Max F. Meyer,et al.  The Proof and Measurement of Association between Two Things. , 1904 .

[120]  S. B. Kater,et al.  Impaired Spatial Learning in L-Calcium-Calmodulin Kinase Mutant Mice , 2022 .